BALA CYNWYD, Pa., Jan. 13, 2015 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of NPS
Pharmaceuticals, Inc. ("NPS" or "the Company") (Nasdaq-NPSP-News)
for possible breaches of fiduciary duty and other violations of
state law in connection with the sale of the Company to Shire
plc.("Shire").
Click here to learn more about the investigation
http://brodsky-smith.com/876-npsp-nps-pharmaceuticals-inc.html, or
call 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, NPS shareholders will
receive $46.00 in cash for each share
of NPS stock they own. The investigation concerns whether the Board
of NPS breached their fiduciary duties to stockholders
by failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Shire is underpaying for NPS
shares. The transaction may undervalue NPS given the market
for the Company's GATTEX/REVESTIVE drug for injection that is
approved to treat adults with short bowel syndrome. In
addition, prior to the announcement, an analyst had set a
$50.00 per share price target on NPS
stock.
If you own shares of NPS common stock and wish to discuss the
legal ramifications of the investigation, or have any
questions, you may e-mail or call the law office of Brodsky
& Smith, LLC who will, without obligation or cost to you,
attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/876-npsp-nps-pharmaceuticals-inc.html, or
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert--brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-nps-pharmaceuticals-inc-300020294.html
SOURCE Brodsky & Smith, LLC